兴齐眼药：公司0.02%、0.04%硫酸阿托品滴眼液已获得药品注册批件

Group 1 - The company Xingqi Eye Medicine has received drug registration approval from the National Medical Products Administration for its 0.02% and 0.04% atropine sulfate eye drops on January 4, 2026 [2] - The company is currently coordinating its market promotion plan and is in the production preparation stage [2]